HMGCR and breast carcinoma: In this investigation lovastatin lactone was shown to induce growth inhibitory effects on human breast cancer cells by inhibition of the proteasome, whereas pravastatin, a ring-open and therefore direct HMG-CoA reductase-inhibitory statin with a structure and potency similar to lovastatin acid, did not elicit comparable effects [21].